易方达中证创新药产业ETF(516080)财务指标
| |
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
| 本期已实现收益 |
-52,448,945.09 |
-26,894,222.23 |
-23,979,364.75 |
-2,798,135.47 |
| 本期利润 |
-45,327,947.06 |
-81,035,832.19 |
-24,690,308.75 |
-33,044,862.74 |
| 加权平均基金份额本期利润 |
-0.08 |
-0.15 |
-0.06 |
-0.08 |
| 本期加权平均净值利润率(%) |
-15.68 |
-29.34 |
-8.73 |
-12.32 |
| 本期基金份额净值增长率(%) |
-13.63 |
-25.12 |
-8.78 |
-11.10 |
| 期末可供分配利润 |
-299,135,782.29 |
-296,247,533.71 |
-187,255,868.28 |
-180,543,447.60 |
| 期末可供分配基金份额利润 |
-0.46 |
-0.53 |
-0.38 |
-0.39 |
| 期末基金资产净值 |
347,419,017.71 |
258,307,266.29 |
308,298,931.72 |
278,011,352.40 |
| 期末基金份额净值 |
0.54 |
0.47 |
0.62 |
0.61 |
| 基金份额累计净值增长率(%) |
-46.27 |
-53.42 |
-37.79 |
-39.37 |
微信公众号
证券之星APP
基本资料
